December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

126.57 -0.47 (-0.37%)
Streaming Delayed Price Updated: 2:12 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
51 52 Next >
News headline image
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified... 
Via StockStory
News headline image
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,... 
Via StockStory
News headline image
Biotech Stocks Stay Strong Through A Period Of Uncertainty In The Market ↗
Many analysts are feeling better about the prospects for healthcare stocks in 2025. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers. 
Via StockStory
News headline image
Looking Into Abbott Laboratories's Recent Short Interest ↗
 
Via Benzinga
News headline image
This Is What Whales Are Betting On Abbott Laboratories ↗
 
Via Benzinga
News headline image
Market Whales and Their Recent Bets on ABT Options ↗
 
Via Benzinga
News headline image
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom ↗
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential. 
Via Benzinga
News headline image
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. ↗
Via The Motley Fool
News headline image
Rep. Emily Randall Has Sold Up to $165K Worth Of Abbott Laboratories Stock: Here's What You Should Know ↗
 
Via Benzinga
News headline image
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now ↗
Via The Motley Fool
News headline image
Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best... 
Via StockStory
News headline image
Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
3 Fabulous Dividend Stocks to Buy in February ↗
Via The Motley Fool
News headline image
3 Dividend Growth Stocks For Intergenerational Wealth ↗
Long-term investors can create intergenerational wealth with dividend growth investing. 
Via Talk Markets
Topics Stocks / Equities
News headline image
2 Unstoppable Dividend Stocks That Will Pay You for Life ↗
Via The Motley Fool
News headline image
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars
Pharmaceutical company AbbVie (NYSE:ABBV) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 5.6% year on year to $15.1 billion. Its non-GAAP profit of $2.16 per share... 
Via StockStory
News headline image
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit of $1.34... 
Via StockStory
News headline image
9 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? 'Something May Be Wrong Here' ↗
Cramer takes a look at TETRA Technologies, Abbott, Wendy's, Nu Holdings and Casella Waste on the latest edition of "Mad Money." 
Via Benzinga
News headline image
Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
Abbott Laboratories Will Outperform Healthcare Stocks in 2025
Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026. 
Via MarketBeat
News headline image
Why Is Abbott Stock Trading Higher On Thursday? ↗
Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices. 
Via Benzinga
News headline image
Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stock ↗
 
Via Benzinga
News headline image
US Stock Futures Trade Mixed After Skirting Record Highs In Last Session: GE Aerospace, American Airlines, Union Pacific In Focus ↗
U.S. stock futures were mixed on Thursday following Wednesday's rally. Futures of benchmark indices were lower except Dow Jones. 
Via Benzinga
Topics Stocks
News headline image
My Top 5 Stocks to Buy in Early 2025 ↗
Via The Motley Fool
News headline image
S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zone ↗
 
Via Benzinga
Topics Stocks
News headline image
S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run ↗
Market surges on AI Stargate initiative & strong earnings. S&P 500 hits record high of 6,100 points, led by tech giants & semiconductor stocks. 
Via Benzinga
Topics Artificial Intelligence Government Stocks
News headline image
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales ↗
 
Via Benzinga
News headline image
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript ↗
ABT earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
51 52 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.